Deregulation of Beclin 1 in patients with tobacco-related oral squamous cell carcinoma

Biochemical and Biophysical Research Communications

Volumn 422, Issue 4, 2012, Pages 764-769

  Kapoor, Vaishali ^a   Paliwal, Daizy ^a   Baskar Singh, S ^a   Mohanti, Bidhu Kalyan ^b   Das, Satya Narayan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Autophagy; Beclin 1; Expression; Oral cancer; SPR

Indexed keywords

BECLIN 1; MESSENGER RNA;

ADULT; AGED; ARTICLE; AUTOPHAGY; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; TOBACCO; TUMOR VOLUME;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; TOBACCO; YOUNG ADULT;

MAMMALIA; NICOTIANA TABACUM;

EID: 84862290411     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.079     Document Type: Article

References (33)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin. 2011, 61:69-90.
2. Saranath D. Epidemiology and prevention of head and neck cancer: a global view. Contemporary Issues in Oral Cancer 2000, Oxford University Press.
3. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics. CA Cancer J. Clin. 2008, 58(2008):71-96.
4. Kapoor V., Singh A.K., Dey S., Sharma S.C., Das S.N. Circulating cycloxygenase-2 in patients with tobacco-related intraoral squamous cell carcinoma and evaluation of its peptide inhibitors as potential antitumor agent. J. Cancer Res. Clin. Oncol. 2010, 136:1795-1804.
5. Sun Y., Peng Z.-L. Autophagy, Beclin 1, and their relation to oncogenesis. Lab Med. 2008, 39:287-290.
6. Li C., Capan E., Zhao Y., Zhao J., Stolz D., Watkins S.C., et al. Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J. Immunol. 2006, 177:5163-5168.
7. Malicdan M.C.V., Noguchi S., Nishino I. Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Autophagy 2007, 3:396-398.
8. Erlich S., Shohami E., Pinkas-Kramarski R. Neurodegeneration induces upregulation of Beclin 1. Autophagy 2006, 2:49-51.
9. Vergne I., Singh S., Roberts E., Kyei G., Master S., Harris J., et al. Autophagy in immune defense against Mycobacterium tuberculosis. Autophagy 2006, 2:175-178.
10. Kondo Y., Kondo S. Autophagy and cancer therapy. Autophagy 2006, 2:85-90.
11. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
12. Yue Z., Jin S., Yang C., Levine A.J., Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. USA 2003, 100:15077-15082.
13. Zeng X., Overmeyer J.H., Maltese W.A. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J. Cell. Sci. 2006, 119:259-270.
14. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112:1809-1820.
15. Kihara A., Kabeya Y., Ohsumi Y., Yoshimori T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2001, 2:330-335.
16. Sun Q., Fan W., Zhong Q. Regulation of Beclin 1 in autophagy. Autophagy 2009, 5:713-716.
17. Wang J. Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy 2008, 4:947-948.
18. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.-H., et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 2006, 8:688-699.
19. Aita V.M., Liang X.H., Murty V.V., Pincus D.L., Yu W., Cayanis E., et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
20. Koneri K., Goi T., Hirono Y., Katayama K., Yamaguchi A. Beclin 1 gene inhibits tumor growth in colon cancer cell lines. Anticancer Res. 2007, 27:1453-1457.
21. Miracco C., Cosci E., Oliveri G., Luzi P., Pacenti L., Monciatti I., et al. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int. J. Oncol. 2007, 30:429-436.
22. Daniel F., Legrand A., Pessayre D., Borrega-Pires F., Mbida L., Lardeux B., et al. Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma. Cancer Invest. 2007, 25:226-231.
23. Ahn C.H., Jeong E.G., Lee J.W., Kim M.S., Kim S.H., Kim S.S., et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. Apmis 2007, 115:1344-1349.
24. Chen N., Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim. Biophys. Acta 2009, 1793:1516-1523.
25. Chen Y., Lu Y., Lu C., Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol. Oncol. Res. 2009, 15:487-493.
26. Ding Z.-B., Shi Y.-H., Zhou J., Qiu S.-J., Xu Y., Dai Z., et al. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 2008, 68:9167-9175.
27. Shen Y., Li D.-D., Wang L.-L., Deng R., Zhu X.-F. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008, 4:1067-1068.
28. Won K.Y., Kim G.Y., Kim Y.W., Song J.Y., Lim S.-J. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum. Pathol. 2010, 41:107-112.
29. Huang X., Bai H.-M., Chen L., Li B., Lu Y.-C. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J. Clin. Neurosci. 2010, 17:1515-1519.
30. Pirtoli L., Cevenini G., Tini P., Vannini M., Oliveri G., Marsili S., et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 2009, 5:930-936.
31. Zhu H., Wu H., Liu X., Li B., Chen Y., Ren X., et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009, 5:816-823.
32. Ogier-Denis E., Codogno P. Autophagy: a barrier or an adaptive response to cancer. Biochim. Biophys. Acta 2003, 1603:113-128.
33. Cao Y., Klionsky D.J. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 2007, 17:839-849.